The Boston startup teaching an AI named Nora to do the one thing sleep clinics never had time for: call the patient back.
The wordmark of a company that started with a sleepless founder. Neru Health, Boston - where a personal medical dead-end became a product spec.
The tidy version of a healthcare startup pitch goes: founder identifies a large, inefficient market and builds software to fix it. The Neru Health version is less tidy and more believable. Morgan Moncada had obstructive sleep apnea and insomnia, and he could not get anyone in the system to help him fix it. Not the clinic, not the equipment supplier, not the follow-up call that never came. That gap - the silence after a patient is handed a machine and sent home - is the entire business.
Here is the thing about durable medical equipment, or DME, the unglamorous corner of healthcare that supplies CPAP machines, oxygen concentrators, and the masks and tubing that keep them running. The device is the easy part. The hard part is what happens over the next ninety days, when a patient decides - consciously or not - whether they will actually keep using the thing. A large share of CPAP users quit early. When they quit, the provider loses reimbursements it will never recover, and the patient goes back to not sleeping. It is a slow, quiet, expensive failure that happens tens of thousands of times a night.
Neru Health's bet, spun out of Harvard's Blavatnik Life Science Fellowship in 2023, is that this is not a willpower problem. It is an operations problem. Patients do not abandon therapy because they are lazy; they abandon it because their mask leaks at 11pm and nobody picks up the phone. So Neru built the thing that picks up the phone. Her name is Nora.
Figures reported by the company; independent verification pending.
Nora is described by Neru not as a chatbot but as a "virtual team member" - an AI active sleep coach that texts, calls, and emails patients across the full arc of their therapy. She walks a first-time user through setting up a CPAP machine. She troubleshoots a leaking mask. She connects to the patient's compliance data and nudges them when the numbers slip. And when the supplies wear out, she coordinates the mask replacement and reorders the parts before anyone has to think about it.
The counterintuitive result buried in Neru's numbers is that automating this work does not make patients feel more abandoned - it reportedly makes them feel more supported. A 20% lift in patient satisfaction sits alongside 30%+ fewer human phone calls. The uncomfortable lesson for anyone who has waited on hold with a medical office is that the "human touch" people actually wanted was mostly just responsiveness, and a machine that answers at midnight clears that bar easily.
An AI sleep coach handling intake, CPAP setup, troubleshooting, adherence coaching, and resupply over text, voice, and email.
A digital-phenotyping engine that sorts patients into behavioral archetypes so Nora knows who needs daily nudges and who needs space.
Automates onboarding, scheduling, compliance tracking, and supply chain - with EHR integration and HIPAA compliance baked in.
“Support Every Patient. Extend Every Team.”- Neru Health's operating thesis, in five words
"Digital phenotyping" is the kind of phrase that makes eyes glaze over until you translate it. What it means for a patient is this: the system figures out what kind of person you are about your own care. Are you the type who responds to a cheerful daily reminder, or the type who finds it nagging and tunes out? Neru's Chronos engine classifies patients into behavioral and clinical archetypes, and Nora adjusts her tone, timing, and frequency accordingly.
In consumer software, personalization is a nice-to-have. In chronic care, it is closer to the whole game - because the difference between a patient who sticks with therapy and one who quits is often just whether the follow-up landed the right way at the right moment.
Neru's founding team did not start with a model looking for a problem. They started with a workflow that was visibly breaking and worked backward. The mix is telling: a life-science operator who lived the problem, a product builder from big-tech and aerospace, and a machine-learning researcher who works on exactly the kind of behavioral modeling the platform runs on.
A decade-plus in life-science startups. Built Neru after failing to get care for his own sleep apnea and insomnia. HBS Blavatnik Fellow.
Digital-phenotyping and generative-AI researcher, formerly at Harvard Business School's D³ Institute.
Product expert with a resume spanning Stanford, Amazon, and Boeing - the operational rigor behind the platform.
Neru's paper trail is early-stage and a little tangled, which is normal for a company this young. Public records show $150,000 in prize capital won in May 2024, followed by a seed round reported at roughly $4 million on a $16 million valuation cap. Some databases still list only the $150K in disclosed dollars - a reminder that early funding data is often incomplete rather than definitive.
Seed round figures and valuation are per public reporting and unconfirmed by the company.
Neru is a B2B AI company. Its customers are the DME providers and sleep clinics; its users are those providers' patients. The pitch to a provider is unusually concrete for healthcare software: recapture reimbursements you were losing to non-adherence, cut the support labor you were spending on repetitive calls, and keep patients on therapy longer. The company says it slots into existing systems - NikoHealth, WellSky, Brightree - rather than asking anyone to rip and replace, which in a conservative industry is often the difference between a signed contract and a polite no.
Notably, Nora is positioned to augment rather than replace clinicians. She does not diagnose. She handles the 200 phone calls the clinic never had time to make - the boring, high-volume, low-judgment work - and leaves the clinical decisions to humans. In a regulated industry, that line is not a limitation; it is the whole reason the product is deployable.
Profile compiled from public sources including Neru Health, Harvard Innovation Labs, HBS AI Institute, HME News, Crunchbase, and PitchBook. Funding, valuation, and performance figures are as reported and may be approximate. Last reviewed July 2026.